cas 170959-40-7|| where to buy 4-Methyl-3-(4-methyloxazol-5-yl)-1H-1,2,4-triazole-5(4H)-thione

Nom du produit:4-Methyl-3-(4-methyloxazol-5-yl)-1H-1,2,4-triazole-5(4H)-thione

IUPAC Name:4-methyl-3-(4-methyl-1,3-oxazol-5-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM191105-1g	1-2 Weeks	ǕȁŴ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 170959-40-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:170959-40-7; Formule moléculaire:C7H8N4OS; Point de fusion:-; Code SMILES:S=C1N(C)C(C2=C(C)N=CO2)=NN1; Densité:

: Numéro de catalogue:CM191105; Poids moléculaire:196.23; Point d'ébullition:; N° Mdl:MFCD09261265; Stockage:Store at 2-8°C.

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.